APA (7th ed.) Citation

Henter, J., von Bahr Greenwood, T., & Bergsten, E. (2020). Emapalumab in Primary Hemophagocytic Lymphohistiocytosis. New England Journal of Medicine, 383(6), 596. https://doi.org/10.1056/NEJMc2020754

Chicago Style (17th ed.) Citation

Henter, Jan-Inge, Tatiana von Bahr Greenwood, and Elisabet Bergsten. "Emapalumab in Primary Hemophagocytic Lymphohistiocytosis." New England Journal of Medicine 383, no. 6 (2020): 596. https://doi.org/10.1056/NEJMc2020754.

MLA (9th ed.) Citation

Henter, Jan-Inge, et al. "Emapalumab in Primary Hemophagocytic Lymphohistiocytosis." New England Journal of Medicine, vol. 383, no. 6, 2020, p. 596, https://doi.org/10.1056/NEJMc2020754.

Warning: These citations may not always be 100% accurate.